기사
Prodizen participates in TOBI International Conference in the US, showcasing Korea's PRP kit technology on the global stage.
- 작성일 : 2025.08.29
- 조회수 : 5
While the International Society of The Orthobiological Institute (TOBI), a global academic conference in regenerative medicine, was held at Caesars Palace in Las Vegas from August 21 to 23, Prodigen said it participated in the conference and successfully completed its schedule.
TOBI is an authoritative symposium held every year on the subject of orthopedic biology and regenerative medicine, where medical staff and researchers from all over the world gather to share the latest clinical data and treatment experiences. In particular, about 200 PRP-related professional doctors attended this year to conduct in-depth discussions and hands-on sessions, continuing practical academic exchanges.
At this conference, Prodizen introduced its sPRP (export name: World PRP) by operating a booth with a local U.S. agency. The sPRP kit features ▲ improved efficiency of procedures through short centrifugation time, ▲ stable performance ▲ structural design that guarantees high results.
These strengths were evaluated as innovative technologies that considered both operator convenience and patient treatment effectiveness, and received high attention from medical staff from all over the world. With this TOBI participation, Prodizen aims to prove the competitiveness of Korea's PRP technology again and leap forward as a global bio company leading renewable healthcare solutions in the global market.
"TOBI is a globally recognized society in the field of regenerative medicine," a Prodizen official said. "Through this participation, we were able to inform the global market of the excellence of Korea's PRP KIT and show that Korean technology can become a world standard. We will continue to innovate so that Korea's PRP technology can become a world standard through continuous research and development."
Meanwhile, Prodizen, founded in 1998, is the first company in Korea to develop PRP tubes and fully introduce PRP procedures to the medical field in Korea. Prodizen, which has accumulated expertise in cell therapy and blood application devices, is collaborating with a number of hospitals, including orthopedics, rehabilitation medicine, and pain medicine, supplying medical devices and integrated solutions for PRP and BMC procedures, and is currently expanding its global network by exporting products to about 30 countries.
다음글